Lentigen Technology, Inc.
Records under this name other than the patents Lentigen Technology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 27 patents it holds.
Back to Lentigen Technology, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,183,993 | Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 10,550,179 | Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 11,970,528 | Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 10,426,797 | Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 10,501,539 | Compositions and Methods For Treating Cancer With Anti-CD19 Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 10,543,263 | Compositions and Methods for Treating Cancer with ANTI-CD22 Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 11,878,052 | Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 10,428,141 | Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 11,453,719 | Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy Formerly held In force · High confidence | In force | High confidence | |
| US 11,708,408 | Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy Formerly held In force · High confidence | In force | High confidence |